CCR2基因多态性与HIV疾病。瑞士HIV队列研究。 - Suppr

Suppr

超能文献

CCR2 polymorphism and HIV disease. Swiss HIV Cohort.

作者信息

Rizzardi G P, Morawetz R A, Vicenzi E, Ghezzi S, Poli G, Lazzarin A, Pantaleo G

出版信息

Nat Med. 1998 Mar;4(3):252-3. doi: 10.1038/nm0398-252.

DOI:10.1038/nm0398-252

PMID:9500580

Abstract

摘要

相似文献

CCR2 polymorphism and HIV disease. Swiss HIV Cohort.

Nat Med. 1998 Mar;4(3):252-3. doi: 10.1038/nm0398-252.

A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.

Nat Med. 1998 Mar;4(3):350-3. doi: 10.1038/nm0398-350.

Effect of CCR2 and CCR5 variants on HIV disease: abstract and commentary.

JAMA. 1997 Dec 17;278(23):2113-4.

Genetic effects on HIV disease progression.

Nat Med. 1998 May;4(5):536. doi: 10.1038/nm0598-536.

Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.

J Infect Dis. 2003 Nov 15;188(10):1461-72. doi: 10.1086/379038. Epub 2003 Nov 18.

Analysis of CCR5, CCR2, CX3CR1, and SDF1 polymorphisms in HIV-positive treated patients: impact on response to HAART and on peripheral T lymphocyte counts.

AIDS Res Hum Retroviruses. 2006 Feb;22(2):153-62. doi: 10.1089/aid.2006.22.153.

A new multiplex PCR strategy for the simultaneous determination of four genetic polymorphisms affecting HIV-1 disease progression.

J Immunol Methods. 2001 Jun 1;252(1-2):147-51. doi: 10.1016/s0022-1759(01)00349-0.

Chemokine receptor polymorphisms and human immunodeficiency virus disease progression.

J Infect Dis. 1999 Oct;180(4):1096-105. doi: 10.1086/314997.

CC chemokine receptor 5 delta32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients.

J Infect Dis. 2002 Dec 15;186(12):1726-32. doi: 10.1086/345677. Epub 2002 Nov 22.

Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.

J Clin Virol. 2005 Dec;34(4):310-4. doi: 10.1016/j.jcv.2005.01.010.

引用本文的文献

Host Factors and HIV-1 Replication: Clinical Evidence and Potential Therapeutic Approaches.

Front Immunol. 2013 Oct 24;4:343. doi: 10.3389/fimmu.2013.00343.

Genetic diversity and linkage disequilibrium in the chemokine receptor CCR2-CCR5 region among individuals and populations.

Cytokine. 2013 Nov;64(2):571-6. doi: 10.1016/j.cyto.2013.08.008. Epub 2013 Sep 5.

Human genetic susceptibility to infectious disease.

Nat Rev Genet. 2012 Feb 7;13(3):175-88. doi: 10.1038/nrg3114.

Common genetic variation and the control of HIV-1 in humans.

PLoS Genet. 2009 Dec;5(12):e1000791. doi: 10.1371/journal.pgen.1000791. Epub 2009 Dec 24.

Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.

J Virol. 2002 Jan;76(2):662-72. doi: 10.1128/jvi.76.2.662-672.2002.

Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes.

Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12004-9. doi: 10.1073/pnas.96.21.12004.

Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.

J Virol. 1999 Aug;73(8):6271-81. doi: 10.1128/JVI.73.8.6271-6281.1999.

Chemokine receptors and chemokines in HIV infection.

J Clin Immunol. 1998 Jul;18(4):243-55. doi: 10.1023/A:1027329721892.

Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4.

J Virol. 1998 Sep;72(9):7450-8. doi: 10.1128/JVI.72.9.7450-7458.1998.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验